The CNAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNAT Detailed Price Forecast - CNN Money||View CNAT Detailed Summary - Google Finance|
|View CNAT Detailed Summary - Yahoo! Finance||View CNAT Stock Research & Analysis - Zacks.com|
|View CNAT Trends & Analysis - Trade-Ideas||View CNAT Major Holders - Barrons|
|View CNAT Call Transcripts - NASDAQ||View CNAT Breaking News & Analysis - Seeking Alpha|
|View CNAT Annual Report - CompanySpotlight.com||View CNAT OTC Short Report - OTCShortReport.com|
|View CNAT Fundamentals - TradeKing||View CNAT SEC Filings - Bar Chart|
|View Historical Prices for CNAT - The WSJ||View Performance/Total Return for CNAT - Morningstar|
|View the Analyst Estimates for CNAT - MarketWatch||View the Earnings History for CNAT - CNBC|
|View the CNAT Earnings - StockMarketWatch||View CNAT Buy or Sell Recommendations - MacroAxis|
|View the CNAT Bullish Patterns - American Bulls||View CNAT Short Pain Metrics - ShortPainBot.com|
|View CNAT Stock Mentions - StockTwits||View CNAT Stock Mentions - PennyStockTweets|
|View CNAT Stock Mentions - Twitter||View CNAT Investment Forum News - Investor Hub|
|View CNAT Stock Mentions - Yahoo! Message Board||View CNAT Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNAT - SECform4.com||View Insider Transactions for CNAT - Insider Cow|
|View CNAT Major Holdings Summary - CNBC||View Insider Disclosure for CNAT - OTC Markets|
|View Insider Transactions for CNAT - Yahoo! Finance||View Institutional Holdings for CNAT - NASDAQ|
|View CNAT Stock Insight & Charts - FinViz.com||View CNAT Investment Charts - StockCharts.com|
|View CNAT Stock Overview & Charts - BarChart||View CNAT User Generated Charts - Trading View|
Conatus Pharmaceuticals Inc. (CNAT) today announced the publication1 of results from preclinical studies of its pan-caspase inhibitor emricasan, demonstrating improvements in portal hypertension (elevated blood pressure in the vein flowing into the liver) and survival in two bile duct ligation mouse models of induced secondary biliary cirrhosis. In the first of the two current mouse studies, designed to evaluate treatment effect, emricasan decreased fibrosis, reduced portal hypertension and improved survival in mice with cirrhosis induced by bile duct ligation. The reductions in portal hypertension exceeded amounts that could be explained by the decreased fibrosis alone, indicating potential treatment effects both inside and outside the liver.
NASH Space in Focus as Galmed (GLMD) Posts Positive Data
Posted on Thursday June 14, 2018
Investor focus is back on the NASH space as quite a few companies release promising data on their NASH candidates of late.
Why Is Conatus Pharmaceuticals (CNAT) Up 4.1% Since Its Last Earnings Report?
Posted on Friday June 01, 2018
Conatus Pharmaceuticals (CNAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Conatus' (CNAT) Q1 Loss In Line, Revenues Beat Estimates
Posted on Thursday May 03, 2018
Conatus (CNAT) reports in-line loss in Q1 while revenues beat estimates. Moreover, the top line improves year over year.